TREM2 regulates microglial cell activation in response to demyelination in vivo
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Microglia are phagocytic cells that survey the brain and perform neuroprotective functions in response to tissue damage, but their activating receptors are largely unknown. Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial immunoreceptor whose loss-of-function mutations in humans cause presenile dementia, while genetic variants are associated with increased risk of neurodegenerative diseases. In myeloid cells, TREM2 has been involved in the regulation of phagocytosis, cell proliferation and inflammatory responses in vitro. However, it is unknown how TREM2 contributes to microglia function in vivo. Here, we identify a critical role for TREM2 in the activation and function of microglia during cuprizone (CPZ)-induced demyelination. TREM2-deficient (TREM2(-/-)) mice had defective clearance of myelin debris and more axonal pathology, resulting in impaired clinical performances compared to wild-type (WT) mice. TREM2(-/-) microglia proliferated less in areas of demyelination and were less activated, displaying a more resting morphology and decreased expression of the activation markers MHC II and inducible nitric oxide synthase as compared to WT. Mechanistically, gene expression and ultrastructural analysis of microglia suggested a defect in myelin degradation and phagosome processing during CPZ intoxication in TREM2(-/-) microglia. These findings place TREM2 as a key regulator of microglia activation in vivo in response to tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the impaired ability of Trem2−/− or Apoe−/− microglia to remove damaged myelin hinders subsequent remyelination (Cantoni et al., 2015; Cantuti-Castelvetri et al., 2018; Poliani et al., 2015; Yeh et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Cantoni et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is a phospholipid sensing receptor known to sustain microglial cell activation and expansion in response to demyelination or amyloid plaques in Alzheimer’s disease (AD) [8, 42, 50].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, our current and previous findings indicate a more complex TREM2 function not only in myelin uptake, but also in promoting myelin debris degradation through the phagolysosomal pathway [8].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, triggering receptor expressed on myeloid cells (TREM) 2, a phospholipid sensing receptor, is expressed by microglia, sustains microglia activity, and mediates myelin debris consumption [200].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [200]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice lacking TREM2, fewer microglia accumulate in the corpus callosum during demyelination due to reduced proliferation which in turn reduces myelin debris clearance [200–202].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [200]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 1×
“0 Bioconductor software [18]; undetectable and low detection value probes were removed.”
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia are motile cells that constantly survey the central nervous system (CNS) parenchyma [10].”
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 2×
“More recently, studies have demonstrated that rare TREM2 genetic variants significantly increase the risk for Alzheimer's disease (AD) [22, 34, 35, 64, 71].”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2×
“More recently, studies have demonstrated that rare TREM2 genetic variants significantly increase the risk for Alzheimer's disease (AD) [22, 34, 35, 64, 71].”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 2×
“In response to tissue injury, microglia undergo a rapid transition from resting, ramified forms to amoeboid morphologies [66].”
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 1×
“These genes are expressed in naïve microglia, but their expression is dramatically reduced after microglia activation [25, 41].”
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511 · cited 5×
“We used two published datasets that define a naïve adult microglia gene expression signature [7, 28] to analyze our list of differentially expressed genes.”
InfluentialMicroglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457 · cited 1×
“DAP12 deficiency results in fewer microglial cells in certain areas of the CNS [36, 60].”
Microglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154 · cited 1×
“In the CNS, TREM2 is specifically expressed by microglial cells, which are believed to be critical for the clearance of tissue debris in homeostatic conditions and during neurologic diseases [51, 52].”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 2×
“…a variety of functions in different myeloid cell types, such as to positively regulate phagocytosis in microglia in vitro [80], to decrease pro-inflammatory responses of mouse macrophages and microglia in vitro [79, 80] and to promote proliferation of immature bone marrow-derived macrophages [59].”
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111 · cited 1×
“In the CNS, TREM2 is specifically expressed by microglial cells, which are believed to be critical for the clearance of tissue debris in homeostatic conditions and during neurologic diseases [51, 52].”
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 2×
“Demyelination was evident after 4 weeks of intoxication in multiple structures, including the cortex, hippocampus, cerebellum, striatum and most notably the corpus callosum [45, 75].”
CSF-1 receptor signaling in myeloid cells.
Stanley, E. R., & Chitu, V. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021857 · Cited by 825 · cited 1×
“Since the TREM2/DAP12 complex cooperates with CSF-1R [59, 60, 76], this could be a mechanism through which TREM2 regulates microglia activities.”
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798 · cited 1×
“Since TREM2 may affect the uptake of aggregated proteins in vitro [38], and clearance of these products is postulated to play a key role in protection from AD and other neurodegenerative proteinopathies [2, 46], it is tempting to speculate that TREM2 mutations could favor neurodegeneration by impairing microglia funct…”
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · cited 1×
“The TREM2 cytoplasmic domain has no intrinsic signaling capacity, but associates with the adaptor molecule DAP12, which can signal through an immunoreceptor tyrosine activation motif (ITAM) and is required for TREM2 surface expression [9, 16].”
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 4×
“…a variety of functions in different myeloid cell types, such as to positively regulate phagocytosis in microglia in vitro [80], to decrease pro-inflammatory responses of mouse macrophages and microglia in vitro [79, 80] and to promote proliferation of immature bone marrow-derived macrophages [59].”
InfluentialSelf-citationPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · cited 2×
“More than 10 years ago it was described that human genetic deficiency of the microglial receptor TREM2 leads to a neurodegenerative disease, PLOSL, characterized by severe brain atrophy with major white matter involvement and diffuse neuronal and axonal loss [61].”
Erblich, B., Zhu, L., Etgen, A. M., Dobrenis, K., & Pollard, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026317 · Cited by 649 · cited 1×
“Moreover, TREM2 and DAP12 promote cell proliferation and survival in response to macrophage colony-stimulating factor (CSF-1) in vitro, the ligand for CSF-1 receptor (CSF-1R) [59, 60] which is required for the development and maintenance of microglia [13, 14].”
Rademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., Lash, J., Wider, C., Wojtas, A., DeJesus-Hernandez, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.1027 · Cited by 571 · cited 1×
“…and IL-34 receptor, CSF - 1R , cause hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented orthochromatic leukodystrophy, two genetic diseases with striking similarities in terms of clinical phenotype and pathological findings with PLOSL, due to TREM2/DAP12 mutations [54, 65].”
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
Durafourt, B. A., Moore, C. S., Zammit, D. A., Johnson, T. A., Zaguia, F., Guiot, M., Bar‐Or, A., & Antel, J. P. (2012) · Glia · doi:10.1002/glia.22298 · Cited by 477 · cited 1×
“Microglia are unique CNS resident myeloid cells that originate from yolk-sac progenitors during embryogenesis and self-renew as an autonomous population throughout life [12, 21].”
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475 · cited 2×
“TREM2 ligands are poorly characterized and include poly-anionic compounds such as bacterial products and neuronal debris, although signaling upon receptor engagement by these compounds has not been proven [11, 30, 50].”
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P.-Y., Suzuki, K., & Matsushima, G. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00168-4 · Cited by 459 · cited 4×
“The CPZ model is a suitable tool to study specifically microglia responses because of minimal CNS infiltration of peripheral inflammatory cells [29, 33].”
InfluentialHamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440 · cited 3×
“TREM2 can promote phagocytosis of apoptotic material and inhibit inflammatory cytokine production in response to apoptotic material and TLR agonists [24, 80, 81].”
TREM and TREM-like receptors in inflammation and disease
Ford, J. W., & McVicar, D. W. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.009 · Cited by 434 · cited 1×
“The TREM2 cytoplasmic domain has no intrinsic signaling capacity, but associates with the adaptor molecule DAP12, which can signal through an immunoreceptor tyrosine activation motif (ITAM) and is required for TREM2 surface expression [9, 16].”
Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040124 · Cited by 414 · cited 1×
“We and others have previously shown a protective role for TREM2 in an animal model for multiple sclerosis, experimental autoimmune encephalomyelitis, in which TREM2 expression was preferentially expressed by resident microglia [63, 78].”
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404 · cited 2×
“Intriguingly, recent reports have also shown an association of TREM2 variants with FTD, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) [3, 5, 8, 67].”
Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., Berger, K., Kipp, M., Baumgärtner, W., & Stangel, M. (2013) · Brain · doi:10.1093/brain/aws262 · Cited by 376 · cited 1×
“Interestingly, Skripuletz et al. [74] showed that depletion of astrocytes in vivo results in a decrease in microglia accumulation, suggesting that astrocytes can also provide signals that promote microglia recruitment and activation to clear debris.”
Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374 · cited 1×
“Furthermore, TREM2 mutations are associated with cases of frontotemporal dementia (FTD)-like syndrome without bone pathology [23].”
Identification of a microglia phenotype supportive of remyelination
Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., & Boddeke, H. W. G. M. (2012) · Glia · doi:10.1002/glia.21266 · Cited by 358 · cited 1×
“This was in accord with a prior report that proposed that LPL could be involved in recycling of lipids from degenerating myelin for use by remyelinating oligodendrocytes [58].”
Otero, K., Turnbull, I. R., Poliani, P. L., Vermi, W., Cerutti, E., Aoshi, T., Tassi, I., Takai, T., Stanley, S. L., Miller, M., et al. (2009) · Nature Immunology · doi:10.1038/ni.1744 · Cited by 315
Self-citationCoding variants in TREM2 increase risk for Alzheimer's disease
Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314 · cited 2×
“More recently, studies have demonstrated that rare TREM2 genetic variants significantly increase the risk for Alzheimer's disease (AD) [22, 34, 35, 64, 71].”
Empirical array quality weights in the analysis of microarray data
Ritchie, M. E., Diyagama, D., Neilson, J., van Laar, R., Dobrovic, A., Holloway, A., & Smyth, G. K. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-261 · Cited by 312
Jha, S., Srivastava, S. Y., Brickey, W. J., Iocca, H., Toews, A., Morrison, J. P., Chen, V. S., Gris, D., Matsushima, G. K., & Ting, J. P.-Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4088-10.2010 · Cited by 310 · cited 1×
“The CPZ model is a suitable tool to study specifically microglia responses because of minimal CNS infiltration of peripheral inflammatory cells [29, 33].”
Piccio, L., Buonsanti, C., Cella, M., Tassi, I., Schmidt, R. E., Fenoglio, C., Rinker, J., Naismith, R. T., Panina-Bordignon, P., Passini, N., et al. (2008) · Brain · doi:10.1093/brain/awn217 · Cited by 307 · cited 1×
“In autopsied multiple sclerosis subjects TREM2 was highly expressed on macrophages/microglia that had engulfed myelin debris [62].”
WOZNIAK, D., HARTMAN, R., BOYLE, M., VOGT, S., BROOKS, A., TENKOVA, T., YOUNG, C., OLNEY, J., & MUGLIA, L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.006 · Cited by 302 · cited 2×
“A battery of sensorimotor tests was performed to assess balance (ledge and platform), strength (inverted screen), coordination (pole and inclined screens) and initiation of movement (walking initiation), as previously described [20, 84].”
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302 · cited 2×
“Another study in an AD mouse model showed a decrease of plaque-associated microglia in mice with only one copy of TREM2 [81].”
Self-citationPattern Recognition by TREM-2: Binding of Anionic Ligands
Daws, M. R., Sullam, P. M., Niemi, E. C., Chen, T. T., Tchao, N. K., & Seaman, W. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.594 · Cited by 291 · cited 3×
“TREM2 ligands are poorly characterized and include poly-anionic compounds such as bacterial products and neuronal debris, although signaling upon receptor engagement by these compounds has not been proven [11, 30, 50].”
Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636837 · Cited by 284 · cited 3×
“TREM2 could directly mediate this interaction as astrocytes have been shown to express binding sites for TREM2 [11, 63].”
Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent
Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070850 · Cited by 271 · cited 1×
“Demyelination was evident after 4 weeks of intoxication in multiple structures, including the cortex, hippocampus, cerebellum, striatum and most notably the corpus callosum [45, 75].”
TREM2 Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis
Cady, J., Koval, E. D., Benitez, B. A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R. H., Ravits, J., Simpson, E., Appel, S. H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6237 · Cited by 262 · cited 2×
“Intriguingly, recent reports have also shown an association of TREM2 variants with FTD, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) [3, 5, 8, 67].”
Luo, J., Elwood, F., Britschgi, M., Villeda, S., Zhang, H., Ding, Z., Zhu, L., Alabsi, H., Getachew, R., Narasimhan, R., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20120412 · Cited by 262 · cited 1×
“Notably, treatment with CSF-1 or IL-34, which increases microglia numbers and internalization of β-amyloid, leads to reduction of amyloid deposition and amelioration of memory deficits in transgenic AD mouse models [4, 42, 49].”
TREM2 and Neurodegenerative Disease
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1306509 · Cited by 254 · cited 2×
“Intriguingly, recent reports have also shown an association of TREM2 variants with FTD, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) [3, 5, 8, 67].”
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Klünemann, H. H., Ridha, B. H., Magy, L., Wherrett, J. R., Hemelsoet, D. M., Keen, R. W., De Bleecker, J. L., Rossor, M. N., Marienhagen, J., Klein, H. E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000160304.00003.ca · Cited by 254
Neumann, H., & Takahashi, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.032 · Cited by 249 · cited 2×
“Most studies have shown that TREM2 is selectively expressed in microglia in the CNS and in osteoclasts in bone, but not in peripheral blood leukocytes in human and mouse in the steady-state or in inflammatory conditions [7, 28, 53].”
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Frank, S., Burbach, G. J., Bonin, M., Walter, M., Streit, W., Bechmann, I., & Deller, T. (2008) · Glia · doi:10.1002/glia.20710 · Cited by 247 · cited 1×
“In transgenic mouse models of AD, TREM2 expression is increased in amyloid plaque-associated microglia, particularly in the outer zone of amyloid plaques [17, 48].”
Ihara, M., Polvikoski, T. M., Hall, R., Slade, J. Y., Perry, R. H., Oakley, A. E., Englund, E., O’Brien, J. T., Ince, P. G., & Kalaria, R. N. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0635-8 · Cited by 244 · cited 1×
“The following primary antibodies were used: anti-MBP (1:100; Abcam, ab7349), -dMBP (1:2000; Millipore, ab5864) [31], - β APP (1:100; Invitrogen, 51-2700), -SMI-31 (1:1000; Covance, smi-31R), - Iba1 (1:600; Wako, 019-19741), -BrdU (1:250; Abcam, ab1893), -GFAP (1:200; Invitrogen, 13-0300), -iNOS…”
TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
N'Diaye, E.-N., Branda, C. S., Branda, S. S., Nevarez, L., Colonna, M., Lowell, C., Hamerman, J. A., & Seaman, W. E. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200808080 · Cited by 239 · cited 1×
“TREM2 ligands are poorly characterized and include poly-anionic compounds such as bacterial products and neuronal debris, although signaling upon receptor engagement by these compounds has not been proven [11, 30, 50].”
Microglial Recruitment, Activation, and Proliferation in Response to Primary Demyelination
Remington, L. T., Babcock, A. A., Zehntner, S. P., & Owens, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060783 · Cited by 234 · cited 1×
“Microglia are the first responders to CPZ-induced injury and their proliferation is largely responsible for Iba1 + cell accumulation with very limited infiltration of monocyte/ macrophages from the periphery [29, 47, 69].”
TREM2 and the neuroimmunology of Alzheimer's disease
Hickman, S. E., & El Khoury, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.021 · Cited by 221 · cited 1×
“Thus, it has been hypothesized that loss-of-function mutations in TREM2 may promote neurotoxic microglial activation [27].”
Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., & Rivest, S. (2008) · Brain · doi:10.1093/brain/awn331 · Cited by 221
affylmGUI: a graphical user interface for linear modeling of single channel microarray data
Wettenhall, J. M., Simpson, K. M., Satterley, K., & Smyth, G. K. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl025 · Cited by 207 · cited 1×
“To identify differentially expressed genes, based on a moderate t test, the Limma package [83] was used, and genes were selected based on a P value cut-off <0.”
MethodVoß, E. V., Škuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., & Stangel, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.008 · Cited by 202 · cited 8×
“In the CPZ model, microglia activation is not accompanied by significantly increased expression of CD45 and CD11b [82].”
InfluentialBrody, D. L., Mac Donald, C., Kessens, C. C., Yuede, C., Parsadanian, M., Spinner, M., Kim, E., Schwetye, K. E., Holtzman, D. M., & Bayly, P. V. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0011 · Cited by 198 · cited 1×
“Rotarod— Motor co-ordination and balance were studied as published [6, 20].”
Xie, M., Tobin, J. E., Budde, M. D., Chen, C.-I., Trinkaus, K., Cross, A. H., McDaniel, D. P., Song, S.-K., & Armstrong, R. C. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e3de90 · Cited by 175 · cited 1×
“It has been reported that axonal APP staining in CPZ treatment decreases between 4 and 12 weeks, without substantial loss of axons [85].”
Self-citationIto, H., & Hamerman, J. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141679 · Cited by 173 · cited 1×
“Moreover, undefined TREM2 ligands are expressed by astrocytes and neurons [11, 30, 63] and by in vitro-generated macrophages and dendritic cells [24, 32].”
Heterozygous TREM2 mutations in frontotemporal dementia
Borroni, B., Ferrari, F., Galimberti, D., Nacmias, B., Barone, C., Bagnoli, S., Fenoglio, C., Piaceri, I., Archetti, S., Bonvicini, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.017 · Cited by 173 · cited 2×
“Intriguingly, recent reports have also shown an association of TREM2 variants with FTD, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) [3, 5, 8, 67].”
Self-citationTREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis
Otero, K., Shinohara, M., Zhao, H., Cella, M., Gilfillan, S., Colucci, A., Faccio, R., Ross, F. P., Teitelbaum, S. L., Takayanagi, H., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102836 · Cited by 171
TREM2 R47H Variant as a Risk Factor for Early-Onset Alzheimer's Disease
Pottier, C., collaborators, G., Wallon, D., Rousseau, S., Rovelet-Lecrux, A., Richard, A.-C., Rollin-Sillaire, A., Frebourg, T., Campion, D., & Hannequin, D. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122311 · Cited by 164 · cited 2×
“More recently, studies have demonstrated that rare TREM2 genetic variants significantly increase the risk for Alzheimer's disease (AD) [22, 34, 35, 64, 71].”
CSF1R mutations link POLD and HDLS as a single disease entity
Nicholson, A. M., Baker, M. C., Finch, N. A., Rutherford, N. J., Wider, C., Graff-Radford, N. R., Nelson, P. T., Clark, H. B., Wszolek, Z. K., Dickson, D. W., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726a7 · Cited by 162 · cited 1×
“Loss-of-function mutations in the gene coding for CSF-1 and IL-34 receptor, CSF-1R, cause hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented orthochromatic leukodystrophy, two genetic diseases with striking similarities in terms of clinical phenotype and pathological findings with PLOSL, due to…”
McMahon, E. J., Suzuki, K., & Matsushima, G. K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00205-9 · Cited by 161 · cited 2×
“In the CPZ model, the increased number of microglia in the CC is mainly due to local microglial proliferation [47, 82].”
Mizuno, T., Doi, Y., Mizoguchi, H., Jin, S., Noda, M., Sonobe, Y., Takeuchi, H., & Suzumura, A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.011 · Cited by 159
Schmid, C. D., Melchior, B., Masek, K., Puntambekar, S. S., Danielson, P. E., Lo, D. D., Gregor Sutcliffe, J., & Carson, M. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05984.x · Cited by 152
Regulation of microglia development and homeostasis.
Greter, M., & Merad, M. (2013) · Glia · doi:10.1002/glia.22408 · Cited by 141 · cited 1×
“Microglia are unique CNS resident myeloid cells that originate from yolk-sac progenitors during embryogenesis and self-renew as an autonomous population throughout life [12, 21].”
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Bayer, T. A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.007 · Cited by 140 · cited 1×
“…in vitro [38], and clearance of these products is postulated to play a key role in protection from AD and other neurodegenerative proteinopathies [2, 46], it is tempting to speculate that TREM2 mutations could favor neurodegeneration by impairing microglia function to clear cell debris and…”
Melchior, B., Garcia, A. E., Hsiung, B.-K., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN Neuro · doi:10.1042/an20100010 · Cited by 134 · cited 1×
“In transgenic mouse models of AD, TREM2 expression is increased in amyloid plaque-associated microglia, particularly in the outer zone of amyloid plaques [17, 48].”
Sieber, M. W., Jaenisch, N., Brehm, M., Guenther, M., Linnartz-Gerlach, B., Neumann, H., Witte, O. W., & Frahm, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052982 · Cited by 130 · cited 1×
“This is consistent with reduced transcription of pro-inflammatory cytokines and chemokines described in TREM2 −/− mice subjected to an inflammatory brain ischemia model in its sub-acute phase [73].”
Lewis, N. D., Hill, J. D., Juchem, K. W., Stefanopoulos, D. E., & Modis, L. K. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.014 · Cited by 127
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus
Norkute, A., Hieble, A., Braun, A., Johann, S., Clarner, T., Baumgartner, W., Beyer, C., & Kipp, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21946 · Cited by 123 · cited 1×
“1c, left panel). dMBP was also quantified with similar results in the CA1 region of the hippocampus which also undergoes demyelination after CPZ treatment [56] (Fig.”
Cerebellar Synaptic Defects and Abnormal Motor Behavior in Mice Lacking α- and β-Dystrobrevin
Grady, R. M., Wozniak, D. F., Ohlemiller, K. K., & Sanes, J. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4823-05.2006 · Cited by 122
Ruiz, A., Dols-Icardo, O., Bullido, M. J., Pastor, P., Rodríguez-Rodríguez, E., López de Munain, A., de Pancorbo, M. M., Pérez-Tur, J., Álvarez, V., Antonell, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.011 · Cited by 118 · cited 2×
“More recently, studies have demonstrated that rare TREM2 genetic variants significantly increase the risk for Alzheimer's disease (AD) [22, 34, 35, 64, 71].”
Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells
Heppner, F. L., Roth, K., Nitsch, R., & Hailer, N. P. (1998) · Glia · doi:10.1002/(sici)1098-1136(199802)22:2<180::aid-glia9>3.0.co;2-b · Cited by 97
Human CNS immune senescence and neurodegeneration
Streit, W. J., & Xue, Q.-S. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.05.005 · Cited by 86 · cited 1×
“Moreover, recent reports have demonstrated that rare variants of TREM2 confer an increased risk to develop common neurodegenerative diseases including AD, FTD, PD and ALS [3, 5, 8, 22, 34, 35, 64, 67, 71, 77].”
Matsuo, A., Lee, G. C., Terai, K., Takami, K., Hickey, W. F., McGeer, E. G., & McGeer, P. L. (1997) · Europe PMC (PubMed Central) · Cited by 79
Benítez, B. A., & Cruchaga, C. (2013) · PubMed Central · doi:10.1056/nejmc1306509#sa4 · Cited by 65
Nishitsuji, K., Hosono, T., Uchimura, K., & Michikawa, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172106 · Cited by 65
Ma, Y., Bao, J., Zhao, X., Shen, H., Lv, J., Ma, S., Zhang, X., Li, Z., Wang, S., Wang, Q., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026864 · Cited by 60 · cited 2×
“LPL is an enzyme implicated in the degradation of lipids that is expressed in microglia in the CNS [19, 43].”
Ultrastructural sequence of myelin degradation: I. Wallerian degeneration in the rat optic nerve
Lassmann, H., Ammerer, H. P., & Kulnig, W. (1978) · Acta Neuropathologica · doi:10.1007/bf00691474 · Cited by 54
Gong, H., Dong, W., Rostad, S. W., Marcovina, S. M., Albers, J. J., Brunzell, J. D., & Vuletic, S. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413505601 · Cited by 51 · cited 1×
“LPL is an enzyme implicated in the degradation of lipids that is expressed in microglia in the CNS [19, 43].”
Ultrastructural sequence of myelin degradation: II. Wallerian degeneration in the rat femoral nerve
Lassmann, H., Ammerer, H. P., JURECKA, W., & Kulnig, W. (1978) · Acta Neuropathologica · doi:10.1007/bf00691475 · Cited by 37
Chromoxane cyanine R. II. Staining of animal tissues by the dye and its iron complexes
Kiernan, J. A. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb00501.x · Cited by 32 · cited 1×
“Solochrome cyanine was used to stain myelin as described [37].”
MethodArchambault, A. S., Sim, J. E., McCandless, E. E., Klein, R. S., & Russell, J. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.012 · Cited by 31 · cited 1×
“Mononuclear cells isolated from the brains as previously described [1] were stained with anti-CD11b phycoerythrin (BD Pharmingen, 553311) and anti-CD45 AF700 (Biolegend, 103128) and sorted on a FACSAria (BD Biosciences).”
Nyrén, R., Chang, C. L., Lindström, P., Barmina, A., Vorrsjö, E., Ali, Y., Juntti‐Berggren, L., Bensadoun, A., Young, S. G., Olivecrona, T., et al. (2012) · BMC Physiology · doi:10.1186/1472-6793-12-14 · Cited by 19 · cited 1×
“…- β APP (1:100; Invitrogen, 51-2700), -SMI-31 (1:1000; Covance, smi-31R), - Iba1 (1:600; Wako, 019-19741), -BrdU (1:250; Abcam, ab1893), -GFAP (1:200; Invitrogen, 13-0300), -iNOS (1:100; BD Pharmingen, 610329), -LPL (1:400, from Dr. G. Olivecrona) [57] and -MHC II (1:100; BD Pharmingen, 553549).”
Research works printed but not linked: 1
- Reitz C Mayeux R TREM2 and neurodegenerative disease. N Engl J Med 2013 369 1564 1565 doi:10.1056/NEJMc1306509#SA1 24131184 PMC3980568 · DOI · Paper page
Cited by
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
“Along with plaque compaction issues, microglia and macrophages lacking TREM2 have been shown to have decreased capacity to phagocytose and clear Ab, apoptotic cells, as well as other proteins and complexes [131,153,154].”
BackgroundMicroglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001
Metadata
- Authors
- Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., Cross, A. H., Otero, K., & Piccio, L.
- Affiliations
- Washington University in St. Louis (US)
- AREA Science Park (IT)
- University of Milan (IT)
- Umeå University (SE)
- Biogen (United States) (US)
- Corresponding author
- Otero, Karel
- Piccio, Laura
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2015-01-29
- Volume
- 129
- Issue
- 3
- Pages
- 429-447
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4667728
- OpenAlex
- W2017867302
- Cited by
- 296
- References
- 87
- Citations by year
- 2026: 24 · 2025: 28 · 2024: 31 · 2023: 34 · 2022: 33 · 2021: 29 · 2020: 22 · 2019: 27 · 2018: 23 · 2017: 19 · 2016: 21 · 2015: 4
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (UL1TR000448)
- National Cancer Institute (P30 CA 91842, P30CA091842)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020579)
- National Institute of Neurological Disorders and Stroke (P01NS059560, R01NS052632)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, microglial activation, demyelination, cuprizone, myelin debris clearance, phagocytosis, myelin degradation, microglial proliferation, MHC class II, inducible nitric oxide synthase, neurodegeneration, axonal pathology
- MeSH terms
- Animals, Brain, Chelating Agents, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Immunohistochemistry, Membrane Glycoproteins, Mice, Inbred C57BL, Receptors, Immunologic, Microscopy, Immunoelectron, Microglia, Mice, Knockout, Oligonucleotide Array Sequence Analysis, Cell Proliferation, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.